Back

When the heart is affected while fighting cancer: immune checkpoint inhibitor–associated myocarditis

11 May 2026 (13:41 - 13:52)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock Clinical Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speakers

Photo
Doctor Goksenin Cansu Ozdogan

Basaksehir Cam and Sakura City Hospital, Istanbul (Turkiye)

Photo
Doctor Sevval Kilic

Basaksehir Pine and Sakura City Hospital, Istanbul (Turkiye)

3 More presentations in this session

Presentation thumbnail
Immune-mediated myocarditis in a patient with metastatic endometrial carcinoma: diagnostic and therapeutic challenges
Doctor M. Pereira Santos (Porto, PT)
Slides Video
Presentation thumbnail
Fulminant immune checkpoint inhibitor related myo-pericarditis complicated by biventricular failure presenting with cardiac tamponade and cardiogenic shock: a clinical case
Doctor T. Nikiforou (Rozzano, IT)
Slides Video
Presentation thumbnail
Immune-related constrictive pericarditis induced by pembrolizumab: a clinical challenge in managing inflammation and heart failure
Mr G. Torres Padilla (Barcelona, ES)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock
Video

The Event

Event poster

Heart Failure 2026

11 May 2026 13:41 CET
You may be interested in
thumbnail
Congress Session
Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock
thumbnail
Congress Presentation
When an anticancer drug silently attacks the heart - severe but due to diabetic neuropathy oligosymptomatic immune checkpoint inhibitor-associated perimyocarditis with LV outflow tract obstruction
thumbnail
Congress Session
Immune checkpoint inhibitors and the heart

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources